资讯

超越减重，再启“心”程！诺和盈中国说明书纳入心血管获益结果
SELECT研究是一项具有里程碑意义的3期心血管结局试验，共纳入17,604例超重或肥胖受试者。其主要结果显示，在标准治疗基础上，诺和盈®相较于安慰剂实现了20%的MACE风险降低。在长达五年的随访时间内，无论受试者基线年龄、性别、人种、种族、基线BMI和肾功能损害程度，均实现了MACE风险降低。此次纳入的数据还包括：诺和盈®可降低心血管死亡风险15%，降低心衰复合终点风险18%，降低全因死亡风险 ...
Dark Energy experiment may change our understanding of the universe “暗能量” 实验 ...
Modern life makes us tired, right? But research from societies in Africa and South America suggests people in the ancient ...
World's largest iceberg runs aground off remote island 世界最大冰山在偏远小岛 ...
Modern life makes us tired, right? But research from societies in Africa and South America suggests people in the ancient ...